Intragenic factor IX restriction site polymorphism in hemophilia B variants

H. J. Hassan, M. Orlando, A. Leonardi, C. Chelucci, R. Guerriero, P. M. Mannucci, G. Mariani, C. Peschle

Research output: Contribution to journalArticlepeer-review


This study includes 47 normal subjects and 25 hemophilia B patients without inhibitor(s), showing different factor IX coagulant activity and antigen levels. Genomic DNA, digested with various restriction endonucleases, was hybridized with two different factor IX probes, ie, the cDNA and the subgenomic probe for the intragenic TaqI polymorphic site. cDNA restriction patterns suggest absence of gross rearrangements and/or deletions in all hemophilic patients. The frequency of the X chromosome bearing the TaqI polymorphic site is 0.32 ± 0.09 in hemophilic subjects v 0.36 ± 0.06 in normal control subjects, the latter value being comparable to that reported for the normal British population. No association between this polymorphism and hemophilia B variants has been observed, thus indicating that a wide spectrum of mutations underlies this blood-clotting disorder and particularly each of its variants.

Original languageEnglish
Pages (from-to)441-443
Number of pages3
Issue number2
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Intragenic factor IX restriction site polymorphism in hemophilia B variants'. Together they form a unique fingerprint.

Cite this